Extended-lister
Coronavirus Archive
-
MSCI Blog
Mar 25, 2020
Asset allocation and index futures during market crises
-
MSCI Blog
Mar 24, 2020
Updating the MSCI Agency MBS model for the COVID-19 crisis
-
MSCI Blog
Mar 20, 2020
How coronavirus could hurt Chinese consumer ABS
-
MSCI Blog
Mar 18, 2020
Real estate is about more than location during uncertain times
-
Research Report
Mar 16, 2020
COVID-19 Outbreak Highlights Gaps in Indian Pharma’s Quality Management
The coronavirus outbreak has applied supply chain shocks to companies relying on China for their raw materials and key supplies. The outbreak has thrown questions of quality management and resilience into sharp relief for Indian pharma companies that could have significant repercussions on the supply of medicines globally. India is the largest provider of generic drugs globally, and generic drugs account for 20% of global exports in terms of volumes. This report explores the...
View | Related products: ESG Products & Services
-
MSCI Blog
Mar 13, 2020
What scenarios has the US equity market priced in?
-
MSCI Blog
Mar 12, 2020
Coronavirus and oil hit equities — how low can we go?
-
MSCI Blog
Mar 6, 2020
Coronavirus and a potential MBS convexity whipsaw
-
MSCI Blog
Mar 5, 2020
The coronavirus market impact spreads globally
-
MSCI Blog
Mar 4, 2020
A coronavirus stress test for global markets